Login / Signup

Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.

Kai JohnsonMajd IssaAnish ParikhPaul MonkMing YinAmir MortazaviYuanquan Yang
Published in: BMC urology (2021)
This case suggests calcitriol-mediated hypercalcemia as a novel immune-related adverse event.
Keyphrases
  • case report
  • metastatic renal cell carcinoma
  • emergency department
  • adverse drug